ARTICLE | Clinical News

Lyrica pregabalin regulatory update

November 8, 2010 8:00 AM UTC

Pfizer said Japan's Ministry of Health, Labor and Welfare (MHLW) approved an expanded label for Lyrica pregabalin capsules to include treatment of peripheral neuropathic pain. In April, the GABA receptor agonist was approved in Japan to treat postherpetic neuralgia. Pfizer co-promotes Lyrica in Japan with Eisai Co. Ltd. (Tokyo:4523; Osaka:4523, Tokyo, Japan). ...